StockData
Globus Medical Inc logo

Globus Medical Inc (GMED) stock

GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$69.99−0.51 (-0.72%)

Close on Nov 17, 2026Market cap $9.40BP/E 17.9Yield –

How the market prices Globus Medical

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Globus Medical trades at 17.9× its earnings, against a median of 37.1× since 2016 — cheaper than 100% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to earnings since 2016

Median 37.1×, today 17.9×

What Globus Medical keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin68.5%vs 55.4%
Operating margin20.3%vs -5.17%
EBITDA margin29.2%vs -2.67%
Pretax margin21.0%vs -2.76%
Net margin17.0%vs -10.3%
Free cash flow margin24.0%vs 0.40%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity11.8%vs -16.3%
Return on assets10.2%vs -12.2%
Return on invested capital12.6%vs -4.33%
Return on capital employed12.8%vs -8.99%

How hard the assets work

Revenue per dollar of assets0.60vs 0.58
Inventory turns a year1.25vs 2.23
Revenue per employee$524.16Kvs $328.95K
Profit per employee$89.24Kvs -$48.85K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $595.14M. That is 6.8% of the $8.80B it would cost to buy the business outright.

Cash and short-term investments$595.14M
EBITDA, trailing twelve months$919.44M
Free cash flow, trailing twelve months$755.59M

Leverage and liquidity

Current ratio4.62vs 2.50
Quick ratio2.69vs 1.55

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

9.56
DistressSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

9 of 9 tests passed

Beneish M-Score

Eight variables that flag accounts shaped to look better than they are.

-2.41
No flagManipulation risk

Price against two rules of thumb

Graham's number and Lynch's fair value, both derived from current earnings.

Graham $55.90Price $69.99Lynch $97.75

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield5.70%vs -5.30%
Free cash flow yield8.04%vs 0.20%
Buyback yield2.35%vs 0.67%
Shareholder yield2.35%vs 0.88%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$69.4952-week low52-week high$101.40
$69.9950-day20-day200-day

The close sits 2% of the way up the 52-week range, 31.0% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

39
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

GMEDS&P 500
PeriodGMEDS&P 500DifferenceGMED per yearS&P 500 per year
1 month-8.8%-4.0%−4.7 pts
3 months-17.8%-5.0%−12.8 pts
Year to date-19.8%+8.2%−28.1 pts
1 year-16.3%+11.2%−27.5 pts
3 years+53.6%+68.5%−14.9 pts+15.4%+19.0%
5 years-0.7%+67.3%−68.0 pts-0.1%+10.8%
10 years+233.1%+291.6%−58.5 pts+12.8%+14.6%

How much it moves

Volatility, 1 year38.4%vs 64.9%
Volume against its 90-day average0.71vs 0.87

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

9M GMED shares were sold short on Oct 30, 2026, up 15.5% from the previous report, or 8.57% of the shares available to trade. At recent volumes it would take 8.1 days to buy them back. Over the last 20 sessions, 53.5% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float8.57%vs 5.08%
Short interest as a share of all shares7.04%vs 3.88%
Days of volume to buy it back8.12vs 3.94

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20269,455,426+15.5%1,165,0338.1
Oct 15, 20268,189,831-2.9%1,497,1155.5
Sep 30, 20268,437,114+24.7%1,640,9325.1
Sep 15, 20266,767,512+2.2%1,469,8904.6
Aug 31, 20266,620,718-2.7%1,013,7546.5
Aug 14, 20266,802,529-1.2%1,721,1964.0
Jul 31, 20266,886,644-2.6%1,409,3794.9
Jul 15, 20267,069,160-4.6%2,018,6573.5
Jun 30, 20267,409,990+35.5%2,079,0683.6
Jun 15, 20265,469,519+39.6%1,595,5023.4
May 29, 20263,916,683+14.7%2,027,3201.9
May 15, 20263,414,228+9.4%2,111,6831.6

Every measure, in full

99 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 23, 2027 (estimated, during market hours)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 17, 2026

Valuation ratiosIndustry

Market Cap
$9.40B
$486.03M
Enterprise Value
$8.80B
$423.26M
PE Ratio
17.90
31.93
PS Ratio
2.99
2.99
PB Ratio
1.97
3.11
P/TBV Ratio
3.56
4.51
P/FCF Ratio
12.44
26.77
P/OCF Ratio
10.32
21.63

Enterprise valuationIndustry

EV / Sales
2.80
2.87
EV / EBITDA
9.57
19.16
EV / EBIT
13.76
24.40
EV / FCF
11.65
28.94

Share statisticsIndustry

Shares Change (YoY)
-1.18%
3.51%
Float
110M
38M
Shares Held by Insiders
17.8%
10.4%
Shares Held by Institutions
88.9%
60.2%

Short sellingIndustry

Short Interest
9M
–
Short Interest Change
15.5%
-2.57%
Short % of Float
8.57%
5.08%
Short % of Shares Outstanding
7.04%
3.88%
Days to Cover
8.12
3.94

Stock price statisticsIndustry

52-Week High
$101.40
–
52-Week Low
$69.49
–
20-Day Moving Average
$77.86
–
50-Day Moving Average
$76.30
–
200-Day Moving Average
$82.50
–
Average True Range (14)
$3.18
–
Price Change (1 Week)
-6.97%
-5.23%
Price Change (1 Month)
-7.48%
-4.69%
Price Change (3 Months)
-20.8%
-10.9%
Price Change (6 Months)
-12.4%
-5.88%
Price Change (YTD)
-19.8%
-6.19%
Price Change (1 Year)
-17.1%
-2.64%
Price Change (3 Years)
53.6%
-2.24%
Price Change (5 Years)
1.24%
-49.5%
Price Change (10 Years)
230.3%
49.2%
Average Volume (10 Days)
3M
–
Average Volume (20 Days)
2M
–
Average Volume (90 Days)
2M
–
Relative Volume
0.71
0.87
Relative Strength Index (14)
38.9
44.0
Volatility (1 Year)
38.4%
64.9%

MarginsIndustry

Gross Margin
68.5%
55.4%
Operating Margin
20.3%
-5.17%
Pretax Margin
21.0%
-2.76%
Profit Margin
17.0%
-10.3%
EBITDA Margin
29.2%
-2.67%
FCF Margin
24.0%
0.40%

Returns on capitalIndustry

Return on Equity (ROE)
11.8%
-16.3%
Return on Assets (ROA)
10.2%
-12.2%
Return on Invested Capital (ROIC)
12.6%
-4.33%
Return on Capital Employed (ROCE)
12.8%
-8.99%

Financial positionIndustry

Current Ratio
4.62
2.50
Quick Ratio
2.69
1.55

GrowthIndustry

Revenue Growth (YoY)
19.7%
9.06%
Net Income Growth (YoY)
50.1%
10.3%
EPS Growth (YoY)
50.4%
12.5%
FCF Growth (YoY)
43.3%
9.29%
Revenue Growth (3Y CAGR)
42.2%
7.08%
Revenue Growth (5Y CAGR)
30.1%
11.8%
EPS Growth (3Y CAGR)
28.4%
3.11%
EPS Growth (5Y CAGR)
31.2%
7.64%

EfficiencyIndustry

Asset Turnover
0.60
0.58
Inventory Turnover
1.25
2.23
Revenue Per Employee
$524.16K
$328.95K
Profits Per Employee
$89.24K
-$48.85K
Employee Count
6,000
193

Income statement (TTM)Industry

Revenue
$3.14B
$104.77M
Gross Profit
$2.16B
$61.99M
Operating Income
$639.52M
-$3.82M
Pretax Income
$660.12M
-$2.12M
Net Income
$535.43M
-$6.19M
EBITDA
$919.44M
-$2.02M
EPS (Diluted)
$3.91
-$0.08

Balance sheetIndustry

Net Cash (Debt)
$595.14M
$3.73M
Net Cash Per Share
$4.43
$0.28
Equity (Book Value)
$4.77B
$63.83M
Book Value Per Share
$35.52
$2.98
Tangible Book Value
$2.64B
$10.75M
Working Capital
$1.74B
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
$910.39M
-$463.66K
Capital Expenditures
-$154.80M
-$3.69M
Free Cash Flow
$755.59M
-$407.03K
FCF Per Share
$5.63
-$0.01

Dividends and yieldsIndustry

Earnings Yield
5.70%
-5.30%
FCF Yield
8.04%
0.20%
Buyback Yield
2.35%
0.67%
Shareholder Yield
2.35%
0.88%

Taxes and interestIndustry

Income Tax
$124.69M
$1.52M
Effective Tax Rate
18.9%
19.0%

Scores and fair valueIndustry

Graham Number
$55.90
$34.74
Graham Upside
-20.1%
-61.3%
Altman Z-Score
9.56
2.40
Piotroski F-Score
9
5
Beneish M-Score
-2.41
-2.64
Lynch Fair Value
$97.75
–
Lynch Upside
39.7%
-49.3%

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?